<!DOCTYPE html>
<html lang="" xml:lang="">
<head>

  <meta charset="utf-8" />
  <meta http-equiv="X-UA-Compatible" content="IE=edge" />
  <title>Apresentação | VIGVAC - Rio de Janeiro</title>
  <meta name="description" content="Análises de efetividade vacinal contra Sars-Cov-2 no estado do Rio de Janeiro." />
  <meta name="generator" content="bookdown 0.24 and GitBook 2.6.7" />

  <meta property="og:title" content="Apresentação | VIGVAC - Rio de Janeiro" />
  <meta property="og:type" content="book" />
  <meta property="og:url" content="https://filustria.github.io/vigvac_rj/" />
  <meta property="og:image" content="https://filustria.github.io/vigvac_rj/C:\Users\Adelson\Desktop\bd vacinas\relatorios\vigvac\docs\par42150-overlay.jpg" />
  <meta property="og:description" content="Análises de efetividade vacinal contra Sars-Cov-2 no estado do Rio de Janeiro." />
  <meta name="github-repo" content="rstudio/bookdown-demo" />

  <meta name="twitter:card" content="summary" />
  <meta name="twitter:title" content="Apresentação | VIGVAC - Rio de Janeiro" />
  
  <meta name="twitter:description" content="Análises de efetividade vacinal contra Sars-Cov-2 no estado do Rio de Janeiro." />
  <meta name="twitter:image" content="https://filustria.github.io/vigvac_rj/C:\Users\Adelson\Desktop\bd vacinas\relatorios\vigvac\docs\par42150-overlay.jpg" />




  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <meta name="apple-mobile-web-app-capable" content="yes" />
  <meta name="apple-mobile-web-app-status-bar-style" content="black" />
  
  
<link rel="prev" href="análises-de-efetividade-vacinal-no-estado-do-rio-de-janeiro.html"/>
<link rel="next" href="análises-de-sobrevida.html"/>
<script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<script src="https://cdn.jsdelivr.net/npm/fuse.js@6.4.6/dist/fuse.min.js"></script>
<link href="libs/gitbook-2.6.7/css/style.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-table.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-bookdown.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-highlight.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-search.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-fontsettings.css" rel="stylesheet" />
<link href="libs/gitbook-2.6.7/css/plugin-clipboard.css" rel="stylesheet" />








<script src="libs/accessible-code-block-0.0.1/empty-anchor.js"></script>
<link href="libs/anchor-sections-1.0.1/anchor-sections.css" rel="stylesheet" />
<script src="libs/anchor-sections-1.0.1/anchor-sections.js"></script>
<script src="libs/kePrint-0.0.1/kePrint.js"></script>
<link href="libs/lightable-0.0.1/lightable.css" rel="stylesheet" />




<link rel="stylesheet" href="style.css" type="text/css" />
</head>

<body>



  <div class="book without-animation with-summary font-size-2 font-family-1" data-basepath=".">

    <div class="book-summary">
      <nav role="navigation">

<ul class="summary">
<li><a href="./">VIGVAC Rio de Janeiro</a></li>

<li class="divider"></li>
<li class="chapter" data-level="" data-path="análises-de-efetividade-vacinal-no-estado-do-rio-de-janeiro.html"><a href="análises-de-efetividade-vacinal-no-estado-do-rio-de-janeiro.html"><i class="fa fa-check"></i>Análises de efetividade vacinal no estado do Rio de Janeiro</a></li>
<li class="chapter" data-level="" data-path="apresentação.html"><a href="apresentação.html"><i class="fa fa-check"></i>Apresentação</a><ul>
<li class="chapter" data-level="" data-path="apresentação.html"><a href="apresentação.html#formas-de-categorizar-o-status-vacinal"><i class="fa fa-check"></i>Formas de categorizar o Status Vacinal:</a></li>
<li class="chapter" data-level="" data-path="apresentação.html"><a href="apresentação.html#resultados-para-o-desfecho-pcr-positivo-para-sars-cov-2"><i class="fa fa-check"></i>Resultados para o desfecho PCR positivo para Sars-Cov-2:</a></li>
</ul></li>
<li class="chapter" data-level="" data-path="análises-de-sobrevida.html"><a href="análises-de-sobrevida.html"><i class="fa fa-check"></i>Análises de Sobrevida</a></li>
<li class="chapter" data-level="" data-path="efetividade-vacinal-variante-delta.html"><a href="efetividade-vacinal-variante-delta.html"><i class="fa fa-check"></i>Efetividade vacinal variante DELTA</a></li>
<li class="chapter" data-level="" data-path="três-doses.html"><a href="três-doses.html"><i class="fa fa-check"></i>Três doses</a></li>
<li class="chapter" data-level="" data-path="rascunho-artigo-delta.html"><a href="rascunho-artigo-delta.html"><i class="fa fa-check"></i>Rascunho artigo Delta</a></li>
<li class="chapter" data-level="" data-path="rascunho-artigo-3-doses.html"><a href="rascunho-artigo-3-doses.html"><i class="fa fa-check"></i>Rascunho artigo 3 doses</a></li>
<li class="divider"></li>
<li><a href="https://github.com/rstudio/bookdown" target="blank">Published with bookdown</a></li>

</ul>

      </nav>
    </div>

    <div class="book-body">
      <div class="body-inner">
        <div class="book-header" role="navigation">
          <h1>
            <i class="fa fa-circle-o-notch fa-spin"></i><a href="./">VIGVAC - Rio de Janeiro</a>
          </h1>
        </div>

        <div class="page-wrapper" tabindex="-1" role="main">
          <div class="page-inner">

            <section class="normal" id="section-">
<div id="apresentação" class="section level1 unnumbered">
<h1>Apresentação</h1>
<p>
 
</p>
<div class="figure">
<img src="docs/013302031809.jpg" alt="" />
<p class="caption">Azulejaria Verde em Carne Viva (2000), Adriana Varejão</p>
</div>
<div id="formas-de-categorizar-o-status-vacinal" class="section level2 unnumbered">
<h2>Formas de categorizar o Status Vacinal:</h2>
<p>
 
</p>
<p><strong><em>Quatro categorias (padrão atual)</em></strong></p>
<ol style="list-style-type: decimal">
<li><strong>Não imunizado (referência)</strong> - do dia da primeira dose até 13 dias após;</li>
<li><strong>Parcialmente vacinado (1 dose)</strong> - de 14 dias após a primeira dose da vacina até o dia da segunda dose da vacina;</li>
<li><strong>Quase</strong> - do dia da segunda dose até 13 dias após a segunda dose da vacina;</li>
<li><strong>Totalmente vacinado (2 doses)</strong> - 14 dias após a segunda dose da vacina até data final da coorte (2021-11-27) ou aplicação da terceira dose.</li>
</ol>
<p>
 
</p>
<p><strong><em>Seis categorias (o que estou usando nas minhas análises)</em></strong></p>
<ol style="list-style-type: decimal">
<li><strong>Pré vacinado</strong> - de 19 de janeiro até o dia da primeira dose da vacina;</li>
<li><strong>Primeira dose</strong> - do dia da primeira dose até 13 dias após;</li>
<li><strong>Parcialmente vacinado</strong> - de 14 dias após a primeira dose da vacina até o dia da segunda dose da vacina;</li>
<li><strong>Quase</strong> - do dia da segunda dose até 13 dias após a segunda dose da vacina;</li>
<li><strong>Totalmente vacinado</strong> - 14 dias após a segunda dose da vacina;</li>
<li><strong>Terceira dose</strong> - do dia da terceira dose da vacina até data final da coorte (2021-11-27).</li>
</ol>
<p>
 
</p>
<p><strong><em>Quatro categorias (outra ideia interessante e mais sucinta)</em></strong></p>
<ol style="list-style-type: decimal">
<li><strong>Pré vacinado</strong> - de 19 de janeiro até 13 dias após a primeira dose;</li>
<li><strong>Primeira dose</strong> - de 14 dias após a primeira dose até 13 dias após a segunda dose;</li>
<li><strong>Segunda dose</strong> - de 14 dias após a segunda dose da vacina até a data da terceira dose (reforço);</li>
<li><strong>Terceira dose</strong> - do dia da terceira dose da vacina até data final da coorte (2021-11-27).</li>
</ol>
<hr />
</div>
<div id="resultados-para-o-desfecho-pcr-positivo-para-sars-cov-2" class="section level2 unnumbered">
<h2>Resultados para o desfecho PCR positivo para Sars-Cov-2:</h2>
<p>
 
</p>
<p><strong><em>Seis categorias (o que estou usando nas minhas análises)</em></strong></p>
<p><strong>AstraZeneca</strong></p>
<table class="table table-striped" style="font-size: 14px; width: auto !important; margin-right: 0; margin-left: auto">
<caption style="font-size: initial !important;">
<span id="tab:unnamed-chunk-2">Table 1: </span>Hazard Ratio (95% CI) para contrair Síndrome Gripal por SarsCov2 no estado do Rio de Janeiro, de acordo com o estado vacinal dos indivíduos imunizados com duas doses de AstraZeneca + dose de reforço com imunizante Pfizer entre Janeiro a Novembro de 2021.
</caption>
<thead>
<tr>
<th style="text-align:left;">
Status vacinal
</th>
<th style="text-align:left;">
Hazard Ratio (95% CI)
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
1ª dose
</td>
<td style="text-align:left;">
1.11 (1.09; 1.14)
</td>
</tr>
<tr>
<td style="text-align:left;">
1ª dose + 14 dias
</td>
<td style="text-align:left;">
0.67 (0.66; 0.68)
</td>
</tr>
<tr>
<td style="text-align:left;">
2ª dose
</td>
<td style="text-align:left;">
0.88 (0.86; 0.9)
</td>
</tr>
<tr>
<td style="text-align:left;">
2ª dose + 14 dias
</td>
<td style="text-align:left;">
0.42 (0.41; 0.42)
</td>
</tr>
<tr>
<td style="text-align:left;">
3ª dose
</td>
<td style="text-align:left;">
0.23 (0.21; 0.25)
</td>
</tr>
</tbody>
<tfoot>
<tr>
<td style="padding: 0; border:0;" colspan="100%">
<sup>*</sup> Porcentagem: Porcentagem da população positiva no momento da vacina
</td>
</tr>
<tr>
<td style="padding: 0; border:0;" colspan="100%">
<sup>†</sup> Valor de referência é não ter tomado nenhuma dose da vacina.
</td>
</tr>
<tr>
<td style="padding: 0; border:0;" colspan="100%">
<sup>‡</sup> Todos os modelos de Hazard proporcionais foram ajustados por sexo, idade do indivíduo e pela porcentagem da população positiva para COVID-19 no momento da aplicação da vacina.
</td>
</tr>
</tfoot>
</table>
<p>
 
</p>
<p><strong>Coronavac</strong></p>
<table class="table table-striped" style="font-size: 14px; margin-right: 0; margin-left: auto">
<caption style="font-size: initial !important;">
<span id="tab:unnamed-chunk-3">Table 2: </span>Hazard Ratio (95% CI) para contrair Síndrome Gripal por SarsCov2 no estado do Rio de Janeiro, de acordo com o estado vacinal dos indivíduos imunizados com duas doses de Coronavac + dose de reforço por imunizante Pfizer entre Janeiro a Novembro de 2021. Valor de referência é não ter tomado nenhuma dose da vacina.
</caption>
<thead>
<tr>
<th style="text-align:left;">
Status vacinal
</th>
<th style="text-align:left;">
Hazard Ratio (95% CI)
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
1ª dose
</td>
<td style="text-align:left;">
1.18 (1.14; 1.21)
</td>
</tr>
<tr>
<td style="text-align:left;">
1ª dose + 14 dias
</td>
<td style="text-align:left;">
1.11 (1.08; 1.13)
</td>
</tr>
<tr>
<td style="text-align:left;">
2ª dose
</td>
<td style="text-align:left;">
0.87 (0.84; 0.9)
</td>
</tr>
<tr>
<td style="text-align:left;">
2ª dose + 14 dias
</td>
<td style="text-align:left;">
0.73 (0.72; 0.73)
</td>
</tr>
<tr>
<td style="text-align:left;">
3ª dose
</td>
<td style="text-align:left;">
0.37 (0.36; 0.39)
</td>
</tr>
</tbody>
</table>
<p>
 
</p>
<p><strong><em>Quatro categorias (padrão atual)</em></strong></p>
<p><strong>AstraZeneca</strong></p>
<table class="table table-striped" style="font-size: 14px; margin-right: 0; margin-left: auto">
<caption style="font-size: initial !important;">
<span id="tab:unnamed-chunk-4">Table 3: </span>Modelo partindo dos 13 primeiros dias pós primeira dose como referência. Hazard Ratio (95% CI) para contrair Síndrome Gripal por SarsCov2 no estado do Rio de Janeiro, de acordo com o estado vacinal dos indivíduos imunizados com duas doses de AstraZeneca + dose de reforço por imunizante Pfizer entre Janeiro a Novembro de 2021. Valor de referência é não ter tomado nenhuma dose da vacina.
</caption>
<thead>
<tr>
<th style="text-align:left;">
Status vacinal
</th>
<th style="text-align:left;">
Hazard Ratio (95% CI)
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
1ª dose + 14 dias
</td>
<td style="text-align:left;">
0.94 (0.92; 0.96)
</td>
</tr>
<tr>
<td style="text-align:left;">
2ª dose
</td>
<td style="text-align:left;">
0.71 (0.69; 0.73)
</td>
</tr>
<tr>
<td style="text-align:left;">
2ª dose + 14 dias
</td>
<td style="text-align:left;">
0.69 (0.67; 0.7)
</td>
</tr>
<tr>
<td style="text-align:left;">
3ª dose
</td>
<td style="text-align:left;">
0.15 (0.13; 0.17)
</td>
</tr>
</tbody>
</table>
<p>
 
</p>
<p><strong>Coronavac</strong></p>
<table class="table table-striped" style="font-size: 14px; margin-right: 0; margin-left: auto">
<caption style="font-size: initial !important;">
<span id="tab:unnamed-chunk-5">Table 4: </span>Modelo partindo dos 13 primeiros dias pós primeira dose como referência. Hazard Ratio (95% CI) para contrair Síndrome Gripal por SarsCov2 no estado do Rio de Janeiro, de acordo com o estado vacinal dos indivíduos imunizados com duas doses de Coronavac + dose de reforço por imunizante Pfizer entre Janeiro a Novembro de 2021. Valor de referência é não ter tomado nenhuma dose da vacina.
</caption>
<thead>
<tr>
<th style="text-align:left;">
Status vacinal
</th>
<th style="text-align:left;">
Hazard Ratio (95% CI)
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
1ª dose + 14 dias
</td>
<td style="text-align:left;">
0.89 (0.87; 0.92)
</td>
</tr>
<tr>
<td style="text-align:left;">
2ª dose
</td>
<td style="text-align:left;">
0.67 (0.65; 0.69)
</td>
</tr>
<tr>
<td style="text-align:left;">
2ª dose + 14 dias
</td>
<td style="text-align:left;">
0.66 (0.64; 0.68)
</td>
</tr>
<tr>
<td style="text-align:left;">
3ª dose
</td>
<td style="text-align:left;">
0.22 (0.2; 0.24)
</td>
</tr>
</tbody>
</table>
<hr />
<p>Este relatório apresenta as análises realizadas no âmbito do estudo VIGVAC dentro do estado do Rio de Janeiro no ano de 2021.</p>
<p>Todas as análises compreende o período que inicia com a data de inauguração do calendário vacinal, em 19 de janeiro de 2021 e terminam no último dia da coorte de seguimento da população - 2021-11-27. O banco de dados compreende informações do banco de vacinações, do banco de notificação de casos de gripe e dos casos de SRAG. O número total de cada banco e suas sobreposições estão distribuidas conforme tabela abaixo.</p>
<p>
 
</p>
<table class=" lightable-paper lightable-hover" style='font-family: "Arial Narrow", arial, helvetica, sans-serif; width: auto !important; margin-left: auto; margin-right: auto;'>
<caption>
<span id="tab:unnamed-chunk-6">Table 5: </span>Número total de indivíduos em cada banco de dados. Rio de Janeiro
</caption>
<thead>
<tr>
<th style="text-align:left;">
Categorias
</th>
<th style="text-align:right;">
Número total
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
SRAG
</td>
<td style="text-align:right;">
23327
</td>
</tr>
<tr>
<td style="text-align:left;">
vacinados
</td>
<td style="text-align:right;">
10400495
</td>
</tr>
<tr>
<td style="text-align:left;">
vacinados&amp;SRAG
</td>
<td style="text-align:right;">
35044
</td>
</tr>
<tr>
<td style="text-align:left;">
Síndrome_gripal
</td>
<td style="text-align:right;">
305456
</td>
</tr>
<tr>
<td style="text-align:left;">
Síndrome_gripal&amp;SRAG
</td>
<td style="text-align:right;">
16975
</td>
</tr>
<tr>
<td style="text-align:left;">
Síndrome_gripal&amp;vacinados
</td>
<td style="text-align:right;">
2383089
</td>
</tr>
<tr>
<td style="text-align:left;">
Síndrome_gripal&amp;SRAG&amp;vacinados
</td>
<td style="text-align:right;">
45075
</td>
</tr>
</tbody>
</table>
<p>
 
</p>
<p>A variável sexo foi corrigida, de 412.697 indefinidos, restaram 35.931, quando combinadas as informações sobre sexo de todas as fontes do banco. Quatro marcas comerciais de imunizantes foram usadas neste período - AstraZeneca, Pfizer, Coronavac e Jansen. A seguir estão as quantidades totais de imunizantes utilizados como primeira, segunda e terceira doses, sem distinção de quais combinações foram feitas.</p>
<p>
 
</p>
<table class=" lightable-paper lightable-hover" style='font-family: "Arial Narrow", arial, helvetica, sans-serif; width: auto !important; margin-left: auto; margin-right: auto;'>
<caption>
<span id="tab:unnamed-chunk-7">Table 6: </span>Número total de DOSES aplicadas no estado do Rio de Janeiro de acordo com a marca comercial
</caption>
<thead>
<tr>
<th style="text-align:left;">
Nome comercial
</th>
<th style="text-align:right;">
Primeira dose
</th>
<th style="text-align:right;">
Segunda dose
</th>
<th style="text-align:right;">
Terceira dose
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:right;">
5168940
</td>
<td style="text-align:right;">
3966133
</td>
<td style="text-align:right;">
25413
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:right;">
3525976
</td>
<td style="text-align:right;">
2924039
</td>
<td style="text-align:right;">
16606
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:right;">
359356
</td>
<td style="text-align:right;">
NA
</td>
<td style="text-align:right;">
408
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
4365215
</td>
<td style="text-align:right;">
2895260
</td>
<td style="text-align:right;">
1688202
</td>
</tr>
<tr>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
430687
</td>
<td style="text-align:right;">
4064742
</td>
<td style="text-align:right;">
12119545
</td>
</tr>
</tbody>
</table>
<p>
 
</p>
<p>Abaixo estão as combinações de imunizantes distribuidos nas três doses feitas na população. Ainda há erros de registro, com pacientes tendo apenas a segunda ou terceira dose registradas.</p>
<p>
 
</p>
<table class=" lightable-paper lightable-hover" style='font-family: "Arial Narrow", arial, helvetica, sans-serif; width: auto !important; margin-left: auto; margin-right: auto;'>
<caption>
<span id="tab:unnamed-chunk-8">Table 7: </span>Número total de PRIMEIRAS DOSES aplicadas no estado do Rio de Janeiro de acordo com a marca comercial
</caption>
<thead>
<tr>
<th style="text-align:left;">
Primeira dose
</th>
<th style="text-align:left;">
Segunda dose
</th>
<th style="text-align:left;">
Terceira dose
</th>
<th style="text-align:right;">
Número total
</th>
</tr>
</thead>
<tbody>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:right;">
2212
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:right;">
9658
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:right;">
11
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
488081
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
3435475
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:right;">
34
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:right;">
24
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
2175
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
12143
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:right;">
139
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:right;">
40
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
1531
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
339111
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:right;">
1090
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:right;">
1011
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:right;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
35049
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
841153
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:right;">
29
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:right;">
107
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
2467
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
17367
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:right;">
15397
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:right;">
4456
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:right;">
207
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
1043830
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
1837980
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:right;">
2
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:right;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
175
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
44823
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:right;">
2235
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:right;">
644
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:right;">
12
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
82844
</td>
</tr>
<tr>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
473397
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
277
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:right;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:right;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
212
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
4
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
493
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:right;">
27
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:right;">
21
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:right;">
32
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
1048
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
357239
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:right;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:right;">
1
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
62
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
10383
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:right;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:right;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
64
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
7508
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:right;">
3333
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:right;">
327
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:right;">
8
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
6018
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
2499252
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:right;">
162
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:right;">
41
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:right;">
3
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
8009
</td>
</tr>
<tr>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
1830035
</td>
</tr>
<tr>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Covid-19-AstraZeneca
</td>
<td style="text-align:right;">
747
</td>
</tr>
<tr>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Covid-19-Coronavac-Sinovac/Butantan
</td>
<td style="text-align:right;">
268
</td>
</tr>
<tr>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag
</td>
<td style="text-align:right;">
131
</td>
</tr>
<tr>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer
</td>
<td style="text-align:right;">
16844
</td>
</tr>
<tr>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:left;">
NA
</td>
<td style="text-align:right;">
412697
</td>
</tr>
</tbody>
</table>

</div>
</div>
            </section>

          </div>
        </div>
      </div>
<a href="análises-de-efetividade-vacinal-no-estado-do-rio-de-janeiro.html" class="navigation navigation-prev " aria-label="Previous page"><i class="fa fa-angle-left"></i></a>
<a href="análises-de-sobrevida.html" class="navigation navigation-next " aria-label="Next page"><i class="fa fa-angle-right"></i></a>
    </div>
  </div>
<script src="libs/gitbook-2.6.7/js/app.min.js"></script>
<script src="libs/gitbook-2.6.7/js/clipboard.min.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-search.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-sharing.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-fontsettings.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-bookdown.js"></script>
<script src="libs/gitbook-2.6.7/js/jquery.highlight.js"></script>
<script src="libs/gitbook-2.6.7/js/plugin-clipboard.js"></script>
<script>
gitbook.require(["gitbook"], function(gitbook) {
gitbook.start({
"sharing": {
"github": false,
"facebook": true,
"twitter": true,
"linkedin": false,
"weibo": false,
"instapaper": false,
"vk": false,
"whatsapp": false,
"all": ["facebook", "twitter", "linkedin", "weibo", "instapaper"]
},
"fontsettings": {
"theme": "white",
"family": "sans",
"size": 2
},
"edit": {
"link": "https://github.com/USERNAME/REPO/edit/BRANCH/02-apresentacao.Rmd",
"text": "Edit"
},
"history": {
"link": null,
"text": null
},
"view": {
"link": null,
"text": null
},
"download": ["_main.pdf", "_main.epub"],
"search": {
"engine": "fuse",
"options": null
},
"toc": {
"collapse": "subsection"
}
});
});
</script>

</body>

</html>
